Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
UTHR · against 89 other Healthcare companies of similar size
Ranked #20 of 90 · scores higher than 78% of peers
Bars: peers in each 10-point band of the valuation score12 peers with a valuation score of 70–79, including UTHR · Click a bar to see the companies
Mainly thanks to its earnings yield, free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | UTHR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 87 reported | 4.6% | 2.8% | 84% | 30% | |
| EBITDA yieldHigher is better · 90 reported | 6.5% | 5.2% | 65% | 50% | |
| Free cash flow yieldHigher is better · 59 reported | 4.2% | 3.6% | 60% | 20% | |
| Book yieldHigher is better · 83 reported | 24.9% | 20.1% | 59% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 21.5B USD | 95 | 60 | |
| 2 | 4.61T JPY (≈$31.3B) | 93 | 76 | |
| 3 | 14.4B USD | 92 | 71 | |
| 4 | 2.57T JPY (≈$17.5B) | 88 | 62 | |
| 5 | 6.17T JPY (≈$42.0B) | 86 | 70 | |
| 17 | 14.9B USD | 72 | 65 | |
| 18 | 5.26T JPY (≈$35.8B) | 71 | 63 | |
| 18 | 14.9B EUR (≈$16.4B) | 71 | 52 | |
| 20 | 27.8B USD | 70 | 55 | |
| 20 | 25.8B USD | 70 | 75 | |
| 22 | 154.4B BRL (≈$27.8B) | 69 | 43 | |
| 22 | 101.7B BRL (≈$18.3B) | 69 | 58 | |
| 24 | 13.9B EUR (≈$15.3B) | 68 | 78 | |
| 24 | 32.8B USD | 68 | 69 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score